Literature DB >> 7679576

Metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) by purified DT-diaphorase under aerobic and anaerobic conditions.

A Cahill1, T C Jenkins, I N White.   

Abstract

Purified DT-diaphorase [NAD(P)H (quinone acceptor) oxidoreductase (EC.1.6.99.2)] from Walker cells was used to investigate the reductive metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) under aerobic and anaerobic conditions. In the presence of NADPH, under aerobic conditions, HPLC analysis showed the four-electron reduction product 3-amino-1,2,4-benzotriazine (SR 4330) was the major reaction product. In contrast, anaerobically, the 2-electron reduction product 3-amino-1,2,4-benzotriazine-1-oxide (SR 4317) was the predominant metabolite. Anaerobic reduction of SR 4233 to the known metabolites SR 4317 and SR 4330, catalyzed by DT-diaphorase, was 3-fold higher than reduction under aerobic conditions. Anaerobically, approximately half of the substrate utilized could not be accounted for by the formation of known products. Aerobically, the majority of the SR 4233 lost could be accounted for by its conversion to SR 4317 and SR 4330. In Walker cells incubated with SR 4233 anaerobically, SR 4317 was the major metabolite formed. Dicoumarol (100 microM) had little effect on the rate of formation of this metabolite in this cell line or in a rat liver epithelial derived (JBJ) cell line. Dicoumarol did however partially reduce the induction of unscheduled DNA synthesis caused by SR 4233 in Walker cells but not in JB1 cells, suggesting the action of dicoumarol may be specific to Walker cells. It is concluded that DT-diaphorase plays only a minor role in the overall reduction of SR 4233 in the two cell lines studied.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679576     DOI: 10.1016/0006-2952(93)90067-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  A mathematical feasibility argument for the use of aptamers in chemotherapy and imaging.

Authors:  Khalid Boushaba; Howard Levine; Marit Nilsen Hamilton
Journal:  Math Biosci       Date:  2009-06-18       Impact factor: 2.144

2.  Toward hypoxia-selective DNA-alkylating agents built by grafting nitrogen mustards onto the bioreductively activated, hypoxia-selective DNA-oxidizing agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).

Authors:  Kevin M Johnson; Zachary D Parsons; Charles L Barnes; Kent S Gates
Journal:  J Org Chem       Date:  2014-07-25       Impact factor: 4.354

3.  Kinetics of Flavoenzyme-Catalyzed Reduction of Tirapazamine Derivatives: Implications for Their Prooxidant Cytotoxicity.

Authors:  Aušra Nemeikaitė-Čėnienė; Jonas Šarlauskas; Violeta Jonušienė; Audronė Marozienė; Lina Misevičienė; Aliaksei V Yantsevich; Narimantas Čėnas
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

4.  Aerobic Cytotoxicity of Aromatic N-Oxides: The Role of NAD(P)H:Quinone Oxidoreductase (NQO1).

Authors:  Aušra Nemeikaitė-Čėnienė; Jonas Šarlauskas; Lina Misevičienė; Audronė Marozienė; Violeta Jonušienė; Mindaugas Lesanavičius; Narimantas Čėnas
Journal:  Int J Mol Sci       Date:  2020-11-19       Impact factor: 5.923

Review 5.  The experimental development of bioreductive drugs and their role in cancer therapy.

Authors:  P Workman; I J Stratford
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.